Stock listing
WGS Stock Price, News, Filings & Events — Genedx Holdings Corp.
Selected listing: WGS · NASDAQ · USD · US
This page tracks Genedx Holdings Corp.'s WGS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following WGS:NASDAQ. WGS:NASDAQ is the stock-level entry point for investors researching Genedx Holdings Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Genedx Holdings Corp. (ticker: WGS) is a public company based in America with a market capitalization of approximately $1.75 billion. The company focuses on providing genetic testing and related services. Genedx aims to enhance healthcare through advanced genomic solutions.
- Ticker
- WGS:NASDAQ
- Asset type
- Stock
- Market cap
- $2.54B
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- NASDAQ
- Currency
- USD
Genedx Holdings Corp. WGS:NASDAQ stock context
This page tracks Genedx Holdings Corp.'s WGS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following WGS:NASDAQ. WGS:NASDAQ is the stock-level entry point for investors researching Genedx Holdings Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Genedx Holdings Corp. (ticker: WGS) is a public company based in America with a market capitalization of approximately $1.75 billion. The company focuses on providing genetic testing and related services. Genedx aims to enhance healthcare through advanced genomic solutions.
Latest news from Genedx Holdings Corp.
GeneDx Reports Second Quarter 2026 Financial Results
August 3, 2026
GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026
July 16, 2026
GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 26, 2026
GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
May 4, 2026
GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
April 13, 2026
Genedx Holdings Corp. earnings calls
GeneDx Holdings Corp. (WGS) Q2 2026 Earnings Call
August 3, 2026 · Replay with transcript and chapters
GeneDx Holdings Corp. (WGS) Q1 2026 Earnings Call
May 4, 2026 · Replay with transcript and chapters
GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call
February 23, 2026 · Replay with transcript and chapters
GeneDx Holdings Corp. (WGS) Q3 2025 Earnings Call
October 28, 2025 · Replay with transcript and chapters
GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call
July 29, 2025 · Replay with transcript and chapters
GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call
April 30, 2025 · Replay with transcript and chapters
Research Genedx Holdings Corp.
Genedx Holdings Corp. investor report
Review AI stock analysis and investor report context for WGS:NASDAQ.
Genedx Holdings Corp. company profile
View the public company page for Genedx Holdings Corp. on 6ix.
Genedx Holdings Corp. news
Read company news and market updates connected to Genedx Holdings Corp..
Genedx Holdings Corp. investor events
Find investor webinars, events, and replay context for Genedx Holdings Corp..